SC
Steven Cohen (Point72) disclosed new in INDIVIOR PHARMACEUTICALS INC
Steven Cohen (Point72) filed a 13F change in INDIVIOR PHARMACEUTICALS INC (45579U109) on 2026-05-15, covering period end 2026-03-31.
Action
New
Capital
$2,893,863 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.